VIVIX | WEECX | VIVIX / WEECX | |
Total Expense Ratio | 0.04 | 1.59 | 3% |
Annual Report Gross Expense Ratio | 0.04 | 1.59 | 3% |
Fund Existence | 27 years | 31 years | - |
Gain YTD | 2.452 | 0.091 | 2,694% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 5000000 | 1000 | 500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 189B | 41.4M | 456,522% |
Annual Yield % from dividends | 2.29 | 0.35 | 651% |
Returns for 1 year | 8.01 | -2.51 | -320% |
Returns for 3 years | 32.19 | 4.81 | 669% |
Returns for 5 years | 72.56 | 5.69 | 1,276% |
Returns for 10 years | 103.54 | -15.27 | -678% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RIEBX | 26.19 | -0.15 | -0.57% |
American Funds Income Fund of Amer R2E | |||
ACGLX | 21.88 | -0.21 | -0.95% |
Invesco Growth and Income R | |||
NCVLX | 11.82 | -0.18 | -1.50% |
Nuance Concentrated Value Institutional | |||
SCMGX | 32.86 | -0.52 | -1.56% |
Sands Capital Global Growth Inst | |||
WPOIX | 11.88 | -0.24 | -1.98% |
Weitz Partners III Opportunity Investor |